| Year |
Citation |
Score |
| 2023 |
Freeman DB, Hopkins TD, Mikochik PJ, Vacca JP, Gao H, Naylor-Olsen A, Rudra S, Li H, Pop MS, Villagomez RA, Lee C, Li H, Zhou M, Saffran DC, Rioux N, et al. Discovery of KB-0742, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of CDK9 for MYC-Dependent Cancers. Journal of Medicinal Chemistry. PMID 37967851 DOI: 10.1021/acs.jmedchem.3c01233 |
0.795 |
|
| 2020 |
Richters A, Doyle SK, Freeman DB, Lee C, Leifer BS, Jagannathan S, Kabinger F, Koren JV, Struntz NB, Urgiles J, Stagg RA, Curtin BH, Chatterjee D, Mathea S, Mikochik PJ, ... ... Pop MS, et al. Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors. Cell Chemical Biology. PMID 33086052 DOI: 10.1016/j.chembiol.2020.10.001 |
0.654 |
|
| 2019 |
Akande OE, Damle PK, Pop M, Sherman NE, Szomju BB, Litovchick LV, Grossman SR. DBC1 Regulates p53 Stability via Inhibition of CBP-Dependent p53 Polyubiquitination. Cell Reports. 26: 3323-3335.e4. PMID 30893604 DOI: 10.1016/J.Celrep.2019.02.076 |
0.415 |
|
| 2019 |
Struntz NB, Chen A, Deutzmann A, Wilson RM, Stefan E, Evans HL, Ramirez MA, Liang T, Caballero F, Wildschut MHE, Neel DV, Freeman DB, Pop MS, McConkey M, Muller S, et al. Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription. Cell Chemical Biology. PMID 30880155 DOI: 10.1016/J.Chembiol.2019.02.009 |
0.531 |
|
| 2018 |
Sandoval GJ, Pulice JL, Pakula H, Schenone M, Takeda DY, Pop M, Boulay G, Williamson KE, McBride MJ, Pan J, St Pierre R, Hartman E, Garraway LA, Carr SA, Rivera MN, et al. Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis. Molecular Cell. PMID 30078722 DOI: 10.1016/J.Molcel.2018.06.040 |
0.499 |
|
| 2016 |
Boskovic ZV, Kemp MM, Freedy AM, Viswanathan VS, Pop MS, Fuller JH, Martinez NM, Figuero Lazu SO, Hong JA, Lewis TA, Calarese D, Love JD, Vetere A, Almo SC, Schreiber SL, et al. Inhibition of zinc-dependent histone deacetylases with a chemically triggered electrophile. Acs Chemical Biology. PMID 27064299 DOI: 10.1021/Acschembio.6B00012 |
0.75 |
|
| 2015 |
Doyle SK, Pop MS, Evans HL, Koehler AN. Advances in discovering small molecules to probe protein function in a systems context. Current Opinion in Chemical Biology. 30: 28-36. PMID 26615565 DOI: 10.1016/J.Cbpa.2015.10.032 |
0.685 |
|
| 2014 |
Pop MS, Wassaf D, Koehler AN. Probing small-molecule microarrays with tagged proteins in cell lysates. Current Protocols in Chemical Biology. 6: 209-20. PMID 25445177 DOI: 10.1002/9780470559277.Ch140101 |
0.674 |
|
| 2014 |
Theurillat JP, Udeshi ND, Errington WJ, Svinkina T, Baca SC, Pop M, Wild PJ, Blattner M, Groner AC, Rubin MA, Moch H, Prive GG, Carr SA, Garraway LA. Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer. Science (New York, N.Y.). 346: 85-89. PMID 25278611 DOI: 10.1126/Science.1250255 |
0.444 |
|
| 2014 |
Pop MS, Stransky N, Garvie CW, Theurillat JP, Hartman EC, Lewis TA, Zhong C, Culyba EK, Lin F, Daniels DS, Pagliarini R, Ronco L, Koehler AN, Garraway LA. A small molecule that binds and inhibits the ETV1 transcription factor oncoprotein. Molecular Cancer Therapeutics. 13: 1492-502. PMID 24737027 DOI: 10.1158/1535-7163.Mct-13-0689 |
0.795 |
|
| 2014 |
Pop M, Stransky N, Garvie C, Theurillat J, Lewis T, Zhong C, Culyba E, Lin F, Daniels D, Pagliarini R, Ronco L, Koehler A, Garraway L. Abstract 2519: A small molecule that binds and inhibits the ETV1 transcription factor oncoprotein Cancer Research. 74: 2519-2519. DOI: 10.1158/1538-7445.Am2014-2519 |
0.777 |
|
| 2010 |
Pop M, Doug K, Bradner J, Koehler A, Garraway L. Abstract 3693: Small molecule microarray screens for inhibitors of oncogenic ETS factors Cancer Research. 70: 3693-3693. DOI: 10.1158/1538-7445.Am10-3693 |
0.759 |
|
| 2007 |
Kaur M, Pop M, Shi D, Brignone C, Grossman SR. hHR23B is required for genotoxic-specific activation of p53 and apoptosis. Oncogene. 26: 1231-7. PMID 16924240 DOI: 10.1038/Sj.Onc.1209865 |
0.302 |
|
| 2004 |
Pop M, Aktories K, Schmidt G. Isotype-specific degradation of Rac activated by the cytotoxic necrotizing factor 1. The Journal of Biological Chemistry. 279: 35840-8. PMID 15143066 DOI: 10.1074/Jbc.M404346200 |
0.364 |
|
| 2004 |
Hoffmann C, Pop M, Leemhuis J, Schirmer J, Aktories K, Schmidt G. The Yersinia pseudotuberculosis cytotoxic necrotizing factor (CNFY) selectively activates RhoA. The Journal of Biological Chemistry. 279: 16026-32. PMID 14761941 DOI: 10.1074/Jbc.M313556200 |
0.342 |
|
| 2002 |
Lerm M, Pop M, Fritz G, Aktories K, Schmidt G. Proteasomal degradation of cytotoxic necrotizing factor 1-activated rac. Infection and Immunity. 70: 4053-8. PMID 12117911 DOI: 10.1128/Iai.70.8.4053-4058.2002 |
0.347 |
|
| Show low-probability matches. |